Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...
Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by ...
Health and Me on MSN
Trump Announces Plans To Cut Ozempic Costs; Doctors Call It A Potential Gamechanger
President Trump announced plans to lower the cost of key medications, including Ozempic, promising more affordable access for ...
In early April, the S&P 500 entered bear market territory, defined by a 20% decline from its recent peak. The index fell to 4 ...
Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by Bay Street pros, advisors and Canadians who invest on their own, they help ...
Welcome back! Trade tensions between China and the United States have flared up again. President Donald Trump is tightening ...
Billionaire celebrity Mark Cuban disrupted the prescription drug industry when he launched the digital pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback